Majority of Clinical Trials for COVID-19 Treatments Fall Short

There are more than 2,000 registered trials for COVID-19 — with more new trials being registered on a daily basis — but researchers say a majority of those trials are lacking key features that would be crucial for determining potential treatments. The studies will likely be inconclusive and require further research because of trial shortcomings which include no defined clinical endpoints to measure success, such as hospital discharge and survival, and a lack of the usual...

Read the Full Article for Free!

You can unsubscribe at any time and I guarantee the privacy of your email. View our privacy policy

Subscribe for FREE to the #1 Natural Health Newsletter or Login for Instant Access

Unlock censored health information that Google doesn't want you to read

Keep your privacy secure — we are one of the few websites that have banned all Google and Facebook scripts to help stop their surveillance capitalism

Get access to all of Dr. Mercola's health articles, E-books and special reports